References
- Vanholder R, Van Biesen W, Lameire N. What is the renal replacement method of first choice for intensive care patients. J Am Soc Nephrol. 2001;12(Suppl 17):S40–S43. doi:10.1681/ASN.V12suppl_1s4011251030
- Russotto V, Cortegiani A, Graziano G, et al. Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria. Infect Drug Resist. 2015;8:287–296. doi:10.2147/IDR.S4881026300651
- Chen Y, Wang C, Chen L. Multidisciplinary cooperation model for prevention and control of ICU MDRO infection [Chinese]. Chin J Hosp Epidemiol. 2018;28(18):2839–2842.
- Cassone M, Mody L. Colonization with multi-drug resistant organisms in nursing homes: scope, importance, and management. Curr Geriatr Rep. 2015;4:87–95. doi:10.1007/s13670-015-0120-225664233
- Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74:417–433. doi:10.1128/MMBR.00016-1020805405
- Hidron AI, Edwards JR, Patel J, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29:996–1011. doi:10.1086/59186118947320
- Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–353. doi:10.1097/01.CCM.0000194725.48928.3A16424713
- Maragakis LL. Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit. Crit Care Med. 2010;38:S345–S351. doi:10.1097/CCM.0b013e3181e6cbc520647792
- Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med. 2010;362:1804–1813. doi:10.1056/NEJMra090412420463340
- Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century — a clinical super-challenge. N Engl J Med. 2009;360:439–443. doi:10.1056/NEJMp080465119179312
- Zhou X, Du G, Li Y, Chen X, Qu H. Detection and drug resistance of MDRO in ICU and non-ICU wards [Chinese]. Chin J Infect Control. 2018;17:219–223+229.
- Vincent JL, Marshall JC, Ñamendys-silva SA, et al. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014;2:380–386. doi:10.1016/S2213-2600(14)70061-X24740011
- Di Gaudio F, Indelicato S, Indelicato S, Tricoli MR, Stampone G, Bongiorno D. Improvement of a rapid direct blood culture microbial identification protocol using MALDI-TOF MS and performance comparison with SepsiTyper kit. J Microbiol Methods. 2018;155:1–7. doi:10.1016/j.mimet.2018.10.01530442592
- (CLSI) Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, Twenty Seventh Informational Supplement. M100S, 27th ed. (CLSI) Clinical and Laboratory Standards Institute; 2017.
- Ministry of Health of the People's Republic of China. Diagnostic criteria of nosocomial infection (trial). Chin Med J. 2001;(05):61–67.
- Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
- Russotto V, Cortegiani A, Fasciana T, et al. What healthcare workers should know about environmental bacterial contamination in the intensive care unit. BioMed Res Int. 2017;2017:6905450. doi:10.1155/2017/690545029214175
- Li F, Yang Y, Liu C, et al. Analysis of infection status and risk factors of multidrug resistant bacteria in ICU [Chinese]. Chin J Hosp Epidemiol. 2016;783–785. Available from: https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2016&filename=ZHYY201604025&uniplatform=NZKPT&v=LkDFIU42_LdJnOxhd_qW1epcLsHsVvbRizUTellR9kP1FFlGM_X_QA4kfTwClzEE. Accessed November 22, 2021.
- Hu F, Guo Y, Zhu D, et al. Surveillance of bacterial drug resistance in China by CHINET in 2017 [Chinese]. Chin J Infect Chemother. 2018. Available from: https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2018&filename=KGHL201803001&uniplatform=NZKPT&v=59T2O-YB7wo-thcTidTPKS3wWecSnGYR8PtPvDTDT5arrcrIDCcZWH3aeTE_Myhi. Accessed November 22, 2021.
- Cui C, Li Q, Tong H, et al. Clinical analysis and drug resistance surveillance of multidrug resistant bacteria infection in intensive care inpatients [Chinese]. Chin J Hosp Epidemiol. 2017;27:2430–2433.
- National bacterial Drug Resistance Surveillance Network (CARSS). National bacterial drug resistance surveillance report; 2017. Available from: http://www.carss.cn/Report/Details?aId=552. Accessed November 19, 2021.
- Zilahi G, Artigas A, Martin-Loeches I. What’s new in multidrug-resistant pathogens in the ICU? Ann Intensive Care. 2016;6:96. doi:10.1186/s13613-016-0199-427714706
- Zhang Y, Gong R, Liu Z, et al. Analysis of 677 cases of nosocomial infection caused by multidrug resistant bacteria. Chin J Hosp Epidemiol. 2017. Available from: https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2017&filename=ZHYY201718010&uniplatform=NZKPT&v=lEMyD8y0s59lx7xCbmCSphzif0-cBjWzWcEOMTAT2nE2k604eI8BwKngHwzFQyF5. Accessed November 22, 2021.
- Chittawatanarat K, Jaipakdee W, Chotirosniramit N, et al. Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit. Infect Drug Resist. 2014;7:203–210. doi:10.2147/IDR.S6726725152627